CLINICAL_TRIALS
trial_result
· 2024-05-29
Clinical Trial Update: A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage [Phase 2]
Summary
Phase 2 trial evaluating semaglutide in non-alcoholic steatohepatitis has completed, with results posted in May 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2024-05-29